I was brought in to help lead the digital paid media practice for a leading global BioTech company.

During this time I discovered anomalies in the data from our primary display advertising Demand Side Platform (DSP) that had existed for more than a year. On their own, the irregularities were not enough to raise any red flags but within the context of the industry it quickly became clear that my client had been billed for millions of impressions which could not have possibly been served given the size of the audience and the frequency caps set in place.

A make-good was immediately negotiated and processes were developed on the front and back end of campaigns to minimize the likelihood of a similar situation occurring in the future, saving the company up to $250,000 in wasted ad spend.